Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 73Recruiting 32Active not recruiting 13Unknown 10Terminated 9Not yet recruiting 2Enrolling by invitation 2Withdrawn 1Suspended 1No longer available 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 26Gastrointestinal 5Breast 5Thoracic 3Gynecologic 3Sarcoma 2Plasma cell 1Other solid neoplasm 1NET 1Endocrine 1Dermatologic 1CNS 1

Conditions

Melanoma 17Carcinoma, Renal Cell 3Skin Neoplasms 2Sarcoma 2Recurrence 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Basal Cell 2Triple Negative Breast Neoplasms 1Thyroid Carcinoma, Anaplastic 1Stomach Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Hypotension 1Gastrointestinal Stromal Tumors 1Eyelid Squamous Cell Carcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Brain Neoplasms 1Basal Cell Nevus Syndrome 1

Interventions

aldesleukin 1Nivolumab 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Prostatic Neoplasms × Dermatologic × Clear all
NCT03970382 2022-08-18

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

PACT Pharma, Inc.

Phase 1 Suspended
21 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡